Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

ConditionOropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorMayo Clinic

About this trial

This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).

Eligibility criteria

Qualifiers

* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester

Age ≥ 18

Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC

Patient has given permission to give his/her blood/saliva sample for research testing

Disqualifiers

* HPV(-) OPSCC

Unable to provide informed consent

Unwilling to attend screening visit at Mayo Clinic site, if indicated

Unwilling/unable to complete surveys electronically

Trial design

Treatments tested in this trial

Non-Interventional Study

Treatment groups

154 Participants

are divided into 1 treatment group

Sponsors and collaborators

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov